FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Instagram Outage Disrupts Thousands of U.S. Users 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
LAGUNA HILLS, Calif., Nov. 09, 2017 -- Bjarne Bergheim, President and Chief Executive Officer of Sonendo® Inc., will be presenting at the 2017 Stifel Health Care Conference. The conference is slated to be held in New York City on Tuesday, November 14. The presentation will begin at 2:00 p.m. Eastern Time.
About the event, Sonendo CEO Bjarne Bergheim said, “It is an honor to be asked to be a presenter at this year’s conference. Sonendo’s mission to save teeth is key to improving the quality of life for patients in need of endodontic therapy, and the GentleWave® System offers patients a superior alternative to standard root canal treatment. The GentleWave Procedure presents the endodontist with the opportunity to expand their referral base by providing better clinical results and a better experience for patients. As we see it, the Sound Science® technology in the GentleWave System is not only a sound investment for a patient’s health, it is also a sound investment for the financial health and success of an endodontic practice.”
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2 For more information, please visit www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact:
Bob Guyatt
Vice President of Marketing
949.766.3636
